Zhejiang Haisen Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 283.17 million compared to CNY 316.17 million a year ago. Revenue was CNY 283.17 million compared to CNY 316.17 million a year ago.

Net income was CNY 71.93 million compared to CNY 82.78 million a year ago. Basic earnings per share from continuing operations was CNY 1.19 compared to CNY 1.62 a year ago. Diluted earnings per share from continuing operations was CNY 1.19 compared to CNY 1.62 a year ago.